AVR-RD-01

( DrugBank: - / KEGG DRUG: - )

1 disease

告示番号	疾患名（ページ内リンク）	臨床試験数
19	ライソゾーム病	1

19. ライソゾーム病

臨床試験数 : 899 / 薬物数 : 684 - (DrugBank : 99) / 標的遺伝子数 : 51 - 標的パスウェイ数 : 182

trials per page:

Showing 1 to 1 of 1 trials

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT03454893 (ClinicalTrials.gov)	February 21, 2018	20/12/2017	Open Label, Study Of Efficacy and Safety Of AVR-RD-01for Treatment-Naive Subjects With Classic Fabry ...	An Open-Label, Multinational Study Of The Efficacy And Safety of Ex Vivo, Lentiviral Vector-Mediated ...	Fabry Disease	Drug: AVR-RD-01	AVROBIO	NULL	Terminated	16 Years	50 Years	Male	11	Phase 1/Phase 2	United States;Australia;Brazil;Canada

First Previous1Next Last